Over 10,000 results
Page 3 of 100
8-K
EX-99.2
zb6i71
6 Jun 24
Treatment with Arbutus’ Imdusiran and VTP-300 Achieves Statistical Significance in Lowering HBsAg Levels
11:16am
N-CSR
4uqv6 g00ixao6
6 Jun 24
Certified annual shareholder report (management investment company)
10:08am
424B3
nd1ghr7
5 Jun 24
Prospectus supplement
4:08pm
S-1/A
nqfhidjx
5 Jun 24
IPO registration (amended)
6:04am
8-K
EX-99.2
qzjprn38vi
5 Jun 24
Arbutus’ Imdusiran with Short Course Interferon Achieves Sustained Undetectable HBsAg, a Necessity for HBV Functional Cure
6:00am
8-K
EX-99.1
hf0rgz3p4y7e6
5 Jun 24
Arbutus’ Imdusiran with Short Course Interferon Achieves Sustained Undetectable HBsAg, a Necessity for HBV Functional Cure
6:00am
PRER14A
vyiduddcwiyf
4 Jun 24
Preliminary revised proxy
8:30pm
6-K
vdit65x
4 Jun 24
Current report (foreign)
4:23pm
SC TO-I
EX-99
rm1iaax ni
3 Jun 24
Issuer tender offer statement
5:10pm
8-K
EX-99.1
r1lsx au5517v7dt
3 Jun 24
Regulation FD Disclosure
4:08pm
6-K
EX-99.1
bsghfgod76g dloofkjr
3 Jun 24
Current report (foreign)
4:05pm
425
EX-99.1
x1dnhn
3 Jun 24
Business combination disclosure
8:50am
8-K
EX-99.1
b39nir8ticpubw
3 Jun 24
Regulation FD Disclosure
8:45am